dextroamphetamine has been researched along with Genetic Predisposition in 5 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The manifestations of daytime somnolence and abnormal sleep behavior have been described in SCA type 3 (SCA3) and SCA type 6 (SCA6), but as yet have not been described in SCA type 1 (SCA1)." | 1.36 | Excessive daytime somnolence in spinocerebellar ataxia type 1. ( Cunnington, D; Dang, D, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hart, AB | 1 |
| Gamazon, ER | 1 |
| Engelhardt, BE | 1 |
| Sklar, P | 1 |
| Kähler, AK | 1 |
| Hultman, CM | 1 |
| Sullivan, PF | 1 |
| Neale, BM | 1 |
| Faraone, SV | 1 |
| de Wit, H | 1 |
| Cox, NJ | 1 |
| Palmer, AA | 1 |
| Yan, TC | 1 |
| McQuillin, A | 1 |
| Thapar, A | 1 |
| Asherson, P | 1 |
| Hunt, SP | 1 |
| Stanford, SC | 1 |
| Gurling, H | 1 |
| Dang, D | 1 |
| Cunnington, D | 1 |
| Dao, DT | 1 |
| Mahon, PB | 1 |
| Cai, X | 1 |
| Kovacsics, CE | 1 |
| Blackwell, RA | 1 |
| Arad, M | 1 |
| Shi, J | 1 |
| Zandi, PP | 1 |
| O'Donnell, P | 1 |
| Knowles, JA | 1 |
| Weissman, MM | 1 |
| Coryell, W | 1 |
| Scheftner, WA | 1 |
| Lawson, WB | 1 |
| Levinson, DF | 1 |
| Thompson, SM | 1 |
| Potash, JB | 1 |
| Gould, TD | 1 |
| Quintanilla, ME | 1 |
| Bustamante, D | 1 |
| Tampier, L | 1 |
| Israel, Y | 1 |
| Herrera-Marschitz, M | 1 |
5 other studies available for dextroamphetamine and Genetic Predisposition
| Article | Year |
|---|---|
Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Dextroamphetamine; Euphoria; Geneti | 2014 |
NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Base Sequence; Case-Control Studies; Corpus | 2010 |
Excessive daytime somnolence in spinocerebellar ataxia type 1.
Topics: Activities of Daily Living; Amantadine; Ataxin-1; Ataxins; Brain Stem; Cerebellum; Citalopram; Dextr | 2010 |
Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans.
Topics: Animals; Behavior, Animal; Calcium Channels, L-Type; Dextroamphetamine; Disease Models, Animal; Fema | 2010 |
Dopamine release in the nucleus accumbens (shell) of two lines of rats selectively bred to prefer or avoid ethanol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Alcoholism; Anesthesia, Inhalation; Animals; Breed | 2007 |